
Bio-Techne Corp.
TECHBio-Techne Corp. (TECH) is a global leader in the development, manufacturing, and distribution of biotechnology and pharmaceutical products. The company specializes in proteins, antibodies, and reagents used in scientific research, clinical diagnostics, and biopharmaceutical development. Founded in 1980, Bio-Techne serves customers across life sciences, healthcare, and biotech industries, providing innovative solutions to advance scientific discovery and improve healthcare outcomes.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| May 29, 2026 | $0.08 | 2026-05-18 | 2026-05-18 |
| February 27, 2026 | $0.08 | 2026-02-13 | 2026-02-16 |
| November 28, 2025 | $0.08 | 2025-11-17 | 2025-11-17 |
| August 29, 2025 | $0.08 | 2025-08-18 | 2025-08-18 |
| May 30, 2025 | $0.08 | 2025-05-19 | 2025-05-19 |
Dividends Summary
- Consistent Payer: Bio-Techne Corp. has rewarded shareholders with 71 dividend payments over the past 18 years.
- Total Returned Value: Investors who held TECH shares during this period received a total of $18.36 per share in dividend income.
- Latest Payout: The most recent dividend of $0.08/share was paid 50 days ago, on May 29, 2026.
- Yield & Schedule: TECH currently pays dividends quarterly with an annual yield of 0.44%.
- Dividend Growth: Since 2008, the dividend payout has decreased by 68.0%, from $0.25 to $0.08.
- Dividend Reliability: TECH has maintained or increased its dividend for 14 consecutive payments.
Company News
Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential violations of federal securities laws and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be limiting superior competing offe...
Bio-Techne shares surged 20% after Merck KGaA announced a $73-per-share cash acquisition offer. The deal comes one week after activist investor Ananym Capital Management built a stake and pushed for a sale. Trading volume reached 51.3M shares, significantly above average. Merck KGaA expects to achieve over $150 million in annual cost synergies wi...
U.S. equities hit fresh record highs on May 6, 2026, with the S&P 500 and Nasdaq 100 reaching all-time peaks. AMD and Super Micro Computer surged 16% on strong AI-driven earnings, while oil prices collapsed 6-7% on diplomatic hopes between Washington and Tehran. Technology stocks led gains, though energy stocks declined sharply. Mixed earnings re...
The global ELISpot & FluoroSpot assay market is projected to grow at a CAGR of 7.1% from 2025 to 2031, driven by increasing adoption of immunology research techniques, personalized immune therapies, and advanced diagnostic assays. Key growth areas include reagent products, pharmaceutical & biotechnology firms, and the APAC region. Major trends in...
Bio-Techne Corporation (NASDAQ: TECH) announced a quarterly dividend of $0.08 per share for the quarter ended December 31, 2025, payable on February 27, 2026, to shareholders of record on February 16, 2026. The company generated over $1.2 billion in net sales in fiscal 2025 and employs approximately 3,100 people worldwide.









